Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY5R | Q15761 | 18/20 | 0.57 |
| ▸ | KCNH2 | Q12809 | 7/20 | 0.57 |
| ▸ | PPARG | P37231 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4478938 | 0.92 | NPY5R (0.61) | NPY5RKCNH2PPARG | |
| SCHEMBL4470110 | 0.85 | NPY5R (0.56) | NPY5RKCNH2 | |
| SCHEMBL4467817 | 0.85 | NPY5R (0.56) | NPY5RKCNH2 | |
| SCHEMBL4463612 | 0.85 | NPY5R (0.56) | NPY5RKCNH2 | |
| SCHEMBL5950682 | 0.82 | NPY5R (0.50) | NPY5RKCNH2 | |
| SCHEMBL5951077 | 0.79 | NPY5R (0.54) | NPY5RKCNH2PPARG | |
| SCHEMBL4476317 | 0.77 | NPY5R (0.60) | NPY5RKCNH2 | |
| SCHEMBL4474237 | 0.77 | NPY5R (0.60) | NPY5RKCNH2 | |
| SCHEMBL4462364 | 0.77 | NPY5R (0.60) | NPY5RKCNH2 | |
| SCHEMBL4466507 | 0.76 | NPY5R (0.64) | NPY5RKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7064142-B2 | Imidazonline compounds | BANYU PHARMACEUTICAL, CO., LTD. (JP) | 2006-06-20 | — | — | US | disclosed |
| US-20030158418-A1 | Novel imidazonline compounds | MSD K.K. (JP) | 2003-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030158418-A1 | Novel imidazonline compounds | NPY1R, NPY2R, GPR119 | NPY5R 4/4885KCNH2 493/4885PPARG 348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.